Does MaxCyte (MXCT) Have the Potential to Rally 85% as Wall Street Analysts Expect?

The average comprises four short-term price targets ranging from a low of $7 to a high of$11, with a standard deviation of $2.06. While the lowest estimate indicates an increase of 40% from the current price level, the most optimistic estimate points to a 120% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. Price, Consensus and EPS Surprise Accordi ...